Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Darzalex

Home/Tag:Darzalex
23 12, 2015

Canadian patients need help getting daratumumab

Tags: , , |0 Comments

My good friend from north of the border, Nancy Shamanna, asked me to share this link to a survey for patients that have taken daratumumab (Darzalex). She's hoping a positive response might move Canadian officials to adopt the new immunotherapy sooner rather than later: Myeloma Canada seeks patient and caregiver treatment input Dear patient/caregiver, Myeloma

8 12, 2015

More drugs are good, but aren’t enough

Tags: , , , , , |9 Comments

Data for more than a dozen "new" myeloma drugs was presented at this week's American Society of Hematology (ASH) meetings here in Orlando. As I described yesterday, several are hopeful crossover drugs; compounds that are already FDA approved for use against other cancers. Keytruda, known chemically as pembrolizumab, and ricolinostat (ACY-1215), another possible cross over

7 12, 2015

BREAKING NEWS: Early data featuring Darzalex in combination with Revlimid

Tags: , , , |6 Comments

As promised, here are details from a preliminary study showing impressive response rates when Darzalex (daratumumab) is combined with Revlimid and dexamethasone. Similarly impressive numbers were also achieved when the immunotherapy drug was used along with pomalidomide. I'll pass along those details later today after that data is presented. Back to Darzalex and Revlimid. Very

25 11, 2015

Financial aid: Takeda wants to help. Lets work together

Tags: , , , , , , , |6 Comments

I had an opportunity to interview several Takeda Pharmaceutical team members about the company's new oral, proteasome inhibitor, Ninlaro (ixazomib), yesterday afternoon. I have heard from dozens of patients who find themselves stuck paying thousands of dollars out-of-pocket for two established oral chemotherapy drugs, Revlimid and Pomalyst. I'm concerned that the same obstacles might face

16 11, 2015

BREAKING NEWS: FDA approves daratumumab

Tags: , , |0 Comments

I expected daratumumab to garner FDA approval sometime after ASH. So when I saw a news alert earlier today announcing that Darzalex had been approved, I didn't pay any attention. But it didn't take long for me to figure out that Darzalex is the new trade name for daratumumab. By any name, this is wonderful